BSE filing, NSE: RAMBHAJO. Summary written from the filing by ALFA Finder's alert engine.
Advit Jewels Ltd: key numbers
- Share price
- ₹362.55
- Market cap
- ₹1,661 Cr
- Revenue (annual)
- ₹167.0 Cr
- Net profit (annual)
- ₹34.39 Cr
- P/E (TTM)
- 35.8×Sector 49.5×
- Promoter holding
- 69.88%+0.00% QoQ
- FII holding
- 1.77%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Advit Jewels Ltd
All →Advit Jewels Capital Structure Change
Ramesh Saraogi raised his Advit Jewels stake from 6.55% to 7.26% through open-market buys. The non-promoter SAST disclosure states no transaction value.
Advit Jewels Board Meeting Date
Advit Jewels will hold a board meeting on 31 October 2026 to consider unaudited financial results for the quarter and half year ended September 2026. The intimation is a prior Regulation 29 notice.
Advit Jewels Capital Structure Change
Non-promoter Ramesh Saraogi and PAC Navratri Share Trading bought 2,00,000 Advit Jewels shares in open market, raising aggregate holding to 6.55%. SAST Reg 29(2) disclosure filed on 19 Oct 2026.
Advit Jewels Promoter Buying (Off-Market)
Advit Jewels promoter Abhishek Gilara acquired 77,78,430 shares via a no-consideration gift from fellow promoter Vipul Gilara. His stake rose to 16.979% through this off-market inter-se transfer.
- Promoter stake change
- +16.98%
Advit Jewels Promoter Selling (Off-Market)
Advit Jewels promoter Vipul Gilara gifted 77,78,430 shares (16.98%) inter-se off-market, reducing his stake to 17.40%. No transaction value was disclosed for the gift transfer.
Advit Jewels Capital Structure Change
Ramesh Sawalram Saraogi and Navratri Share Trading Private Limited acquired 1,00,000 shares of Advit Jewels Limited. Their combined stake increased from 5.82% to 6.11%.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.